Press Corner: Professor Theo Meert, a speaker at the marcus evans Discovery Summit 2012, shares strategies for improving drug discovery efforts. <more>
#tag: to follow us on twitter use #mePharma
Discovery Summit 2011 Website
The life science industry is at a tipping point. Despite the increased amount of spending on research and development, shrinking pipelines accentuate unimpressive performance. Loss of exclusivity due to patent expiration, stricter regulations and cost constraints are just some of the industry challenges that need to be tackled to achieve harmonious revenue streams. Research never stops, and in the midst of this turbulence, pharma, biotech and academia united ought to externalise research and development and simplify operational models. Accessing external innovation, understanding its true value and growing diversified business portfolios holds the key to selecting best targets for therapeutic intervention.
The 12th Annual Discovery Summit is the premium forum bringing elite buyers and sellers together. As an invitation-only event taking place behind closed doors, the summit offers global R&D professionals and drug discovery service providers an intimate environment for a focused discussion of key new drivers shaping discovery research and development.